Obesity and Diabetes
Research reports on obesity and diabetes from University of Kansas provide new insights
Published in Obesity and Diabetes Week, December 24th, 2007
"The aim of this work was to design and utilize a bifunctional peptide inhibitor called glutamic acid decarboxylase-bifunctional peptide inhibitor to suppress the progression of type I diabetes in non-obese diabetic mice. The hypothesis is that glutamic acid decarboxylase-bifunctional peptide inhibitor binds simultaneously to major histocompatibility complex-II and intercellular adhesion molecule type I on antigen-presenting cell and inhibits the immunological synapse formation during T-cell-antigen-presenting cell interactions," investigators in the United States report.
"Glutamic acid decarboxylase-bifunctional peptide inhibitor was composed of a major epitope of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Obesity
Kids more active when playground has balls, jump ropes, UNC study shows - Obesity and Diabetes
Study suggests link between obesity, poor bone health - Obesity and Diabetes
Too much fructose could leave dieters sugar shocked - Obesity and Diabetes
UT Southwestern: Patients with mild Cushing syndrome may benefit from adrenalectomy - Atherosclerosis
Data on atherosclerosis published by B. Strohmer and colleagues - Bioengineering
BioMimetic Therapeutics Reports Positive Clinical Results for GEM OS(R)1 in Canadian Foot and Ankle Fusion Study - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
